Skip to main content
OpenTrials
Completed

NCT Number: NCT02513537

Postoperative Delirium - European Society of Anaesthesiology Survey

The ESA is currently preparing a guideline on the management of postoperative delirium (POD), which attempts to reduce the impact of postoperative delirium and provide recommendations for prevention, diagnostics and treatment of delirium outside the intensive care unit. The guidelines are going to be published during 2015.

While the guideline provides recommendations for daily practice, assessment of current practice and knowledge is of utmost importance, because the implementation and the measurement of a change in clinical practice will be dependent on these measurements.

This Survey has been approved by the Scientific and Research Committees of the European Society of Anaesthesiology (ESA), the Media Committee of the ESA, as well as the institutional ethical committee of Charité - Universitätsmedizin Berlin.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Postoperative Delirium Confusion Delirium Emergence Delirium Mental Disorders Nervous System Diseases Neurobehavioral Manifestations Neurocognitive Disorders Neurologic Manifestations Pathologic Processes Pathological Conditions, Signs and Symptoms Postoperative Complications Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Anaesthesiolgy and Intensive Care Medicine CVK/CCM, Charité - Univeristy Medicine Berlin, Berlin, Germany

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Anaesthesists, nursing staff, which are invited to the online - Survey of the European Society of Anaesthesiology

Treatment and study plan

Primary outcomes

  1. Status of diagnosis of delirium

    Time frame: Up to 6 months

    Answers of ESA-members regarding diagnosis instruments of Delirium. Survey: Multiple Chioce Question. Plus short Essay question to describe prevention (non-structured, non mandatory).

  2. Status of prevention of delirium

    Time frame: Up to 6 months

    Answers of ESA-members regarding prevention measurements of Delirium Survey: Multiple Chioce Question. Plus short Essay question to describe prevention (non-structured, non mandatory).

  3. Status of therapy of delirium

    Time frame: Up to 6 months

    Answers of ESA-members regarding therapy of Delirium. Survey: Multiple Chioce Question. Plus short Essay question to describe prevention (non-structured, non-mandatory).

Secondary outcomes

  1. Status of diagnosis of delirium

    Time frame: Up to one, two and five years

    Answers of ESA-members regarding diagnosis instruments of Delirium. Survey: Multiple Chioce Question. Plus short Essay question to describe prevention (non-structured, non-mandatory).

  2. Status of prevention of delirium

    Time frame: Up to one, two and five years

    Answers of ESA-members regarding prevention measurements of Delirium. Survey: Multiple Chioce Question. Plus short Essay question to describe prevention (non-structured, non-mandatory).

  3. Status of therapy of delirium

    Time frame: Up to one, two and five years

    Answers of ESA-members regarding therapy of Delirium. Survey: Multiple Chioce Question. Plus short Essay question to describe prevention (non-structured, non-mandatory).

Sponsors and collaborators

Lead sponsor

Charite University, Berlin, Germany

Other

Registry information

Important dates

Study start
2015
Primary completion
2020
Study completion
2020
First posted
Jul 31, 2015
Registry last updated
Feb 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.